{"cursor":"10501","size":15,"audio":[],"currentlang":"en","article":"\n\n'Jeffery W. Kelly' (born August 23, 1960 in Medina, New York) is the former Dean\nof Graduate Studies (2000-2008) and Vice President of Academic Affairs (2000-\n2006) and currently is the Chairman of Molecular and Experimental Medicine and\nthe Lita Annenberg Hazen Professor of Chemistry within the Skaggs Institute of\nChemical Biology at The Scripps Research Institute in La Jolla, California. [http://www.scripps.edu/skaggs/kelly/dr_kelly.php?a=l&cid=1 The\nKelly Group], Scripps.edu, Retrieved December 10, 2010 His work focuses on\nunderstanding protein misfolding and aggregation and on developing both\nchemical Johnson, S.; Green, N.; Adamanski-Werner, S.; Kelly, J.W. \"Native\nState Kinetic Stabilization as a Strategy to Ameliorate Protein Misfolding\nDiseases: A focus on the Transthyretin Amyloidoses\" Acct. Chem. Res. 2005 38,\n911-921. and biological strategies Balch, W.E.; Morimoto, R.I.;\nDillin, A.; Kelly, J.W. âAdapting Proteostasis For Disease Interventionâ Science\n2008 319, 916-919. to ameliorate diseases caused by protein misfolding\nand/or aggregation.\n\nKelly received his Ph.D. in organic chemistry from the University of North\nCarolina at Chapel Hill (1986) and performed post-doctoral research at The\nRockefeller University (1986â89). His research focuses on the chemistry and\nbiology of protein homeostasis or [[proteostasis]]. Lindquist, S.L.; Kelly,\nJ.W. âChemical and Biological Approaches for Adapting Proteostasis to Ameliorate\nProtein Misfolding and Aggregation DiseasesâProgress and Prognosisâ Cold Spring\nHarbor Perspect. Biol. doi10.1101 / cshperspect.a004507 2011, 307-340.\nBesides studying the structural and energetic basis behind protein folding, his\nlaboratory also studies the etiology of neurodegenerative diseases linked to\nprotein aggregation, including Alzheimer's disease, Parkinson's Disease, and the\nfamilial gelsolin and transthyretin-based amyloidosesâpublishing over 250 peer-\nreviewed papers in this area to date. He has also provided insight into genetic\ndiseases associated with loss of protein function, such as lysosomal storage\ndiseases. Mu, T-W.; Ong, D.S.T.; Wang, Y-J; Balch, W. E.; Yates, J.R.;\nSegatori, L.; Kelly, J.W. .âChemical and Biological Approaches Synergize to\nAmeliorate Protein-Folding Diseasesâ Cell 2008 134, 769-781. Sawkar,\nA.R.; Cheng, W-C.; Beutler, E.: Wong, C.âH.: Balch, W.E.: Kelly, J.W. \"Chemical\nChaperones Increase the Cellular Activity of N370S Î²-glucosidase: A Therapeutic\nStrategy for Gaucher Disease \" Proc. Natl. Acad. Sci., 2002, 99, 15428-\n15433.\n\nKelly has cofounded three biotechnology companies, FoldRx Pharmaceuticals (with\nSusan Lindquist), now owned by Pfizer, Proteostasis Therapeutics, Inc. (with\nAndrew Dillin and Richard Morimoto) (a private corporation) and Misfolding\nDiagnostics (with Xin Jiang and Justin Chapman; a private corporation). The\nKelly laboratory discovered the first regulatory agency-approved drug that slows\nthe progression of a human amyloid disease Razavi, H.; Palaninathan, S.K.\nPowers, E.T.; Wiseman, R.L.; Purkey, H.E.; Mohamadmohaideen, N.N.; Deechongkit,\nS.; Chiang, K.P.; Dendle, M.T.A.; Sacchettini, J.C.; Kelly, J.W. \"Benzoxazoles\nas Transthyretin Amyloid Fibril Inhibitors: Synthesis, Evaluation and Mechanism\nof Action\" Angew. Chem. Int. Ed. 2003, 42, 2758-2761. using a structure-\nbased design approach. Coelho, T.; Maia, L.F.; Martins da Silva, A.; Cruz,\nM.W.; PlantÃ©-Bordeneuve, V.; Lozeron, P.; Suhr, O.B.; Campistol, J.M.;\nConceiÃ§ao, I.; Schmidt, H.; Trigo, P. Kelly, J.W.; Labaudiniere, R.; Chan, J.,\nPackman, J.; Wilson, A.; Grogan, D.R. âTafamidis for transthyretin familial\namyloid polyneuropathy: a randomized, controlled trialâ Neurology 2012, 79, 785-\n792 This drug, now called Tafamidis or Vyndaqel, Johnson, S.M.;\nConnelly, S.; Fearns, C.; Powers, E.T.; Kelly, J.W. âThe Transthyretin\nAmyloidoses: From Delineating the Molecular Mechanism of Aggregation Linked to\nPathology to a Regulatory Agency Approved Drugâ J. Mol. Biol. 2012 421, 185-\n203. slowed the progression of familial amyloid polyneuropathy in an 18\nmonth placebo controlled trial and in an 18 month extension study sponsored by\nFoldRx Pharmaceuticals (acquired by Pfizer in 2010). Vyndaqel or Tafamidis\nBulawa, C.E.; Connelly, S.; DeVit, M.; Wang, L. Weigel, C.;Fleming, J.\nPackman, J.; Powers, E.T.; Wiseman, R.L.; Foss, T.R.; Wilson, I.A.; Kelly, J.W.;\nLabaudiniere, R. âTafamidis, A Potent and Selective Transthyretin Kinetic\nStabilizer That Inhibits the Amyloid Cascadeâ Proc. Natl. Acad. Sci. 2012 109,\n9629-9634. was approved for the treatment of Familial amyloid\nPolyneuropathy by the European Medicines Agency in late 2011. Kelly also\ndiscovered that diflunisal kinetically stabilizes transthyretin, enabling a\nplacebo controlled clinical trial with it to ameliorate familial amyloid\npolyneuropathyâthe results of which will be announced in 2013. Proteostasis\nTherapeutics, Inc. is developing first-in-class drugs that adapt the\nproteostasis network to ameliorate both loss-of-function misfolding diseases and\ngain-of-toxic function diseases linked to protein aggregation.\n\nIn addition to discovering the first drug that slows the progression of a human\namyloid disease, the Kelly Laboratory is credited with demonstrating that\ntransthyretin conformational changes alone are sufficient for\namyloidogenesis, Colon, W.; Kelly, J.W. \"Partial Denaturation of\nTransthyretin is Sufficient for Amyloid Fibril Formation In Vitro.\"\nBiochemistry, 1992, 31, 8654-8660. discovering the first example of\nfunctional amyloid in mammals, Fowler, D.M.; Koulov, A.V.; Alory-Jost, C.;\nMarks, M.S.; Balch, W.E; Kelly, J.W. \"Functional Amyloid Formation Within\nMammalian Tissue \" PLoS Biology 2006, 4, 100-107. making major\ncontributions toward understanding Î²-sheet folding, discovering the \"enhanced\naromatic sequon\"âsequences that are more efficiently glycosylated by cells and\nsequences which stabilize the proteins that they are incorporated into as a\nconsequence of N-glycosylation Culyba, E.K.; Price, J.L.; Hanson, S.R.;\nDhar, A,; Wong, C-H.; Gruebele, M.; Powers, E.T.; Kelly, J.W. âProtein Native\nState Stabilization by Placing Aromatic Side Chains in N-Glycosylated Reverse\nTurnsâ Science 2011, 331, 571-575. and was corresponding author on and\ncontributed some of the key experimental data demonstrating that altering\ncellular proteostasis capacity has the potential to alleviate protein misfolding\nand aggregation diseases. Balch, W.E.; Morimoto, R.I.; Dillin, A.; Kelly,\nJ.W. âAdapting Proteostasis For Disease Interventionâ Science 2008, 319, 916-\n919.\n\nKelly has won numerous awards including the Biopolymers Murray Goodman Memorial\nPrize, 2012; The American Chemical Society, Ralph F. Hirschmann Award in Peptide\nChemistry, 2012; The Protein Society Emil T. Kaiser Award, 2011; The American\nPeptide Society Rao Makineni Lectureship (Award), 2011; The American Peptide\nSociety Vincent du Vigneaud Award, 2008; National Institutes of Health Merit\nAward, 2006; American Chemical Society Arthur C. Cope Scholar Award, 2001; SUNY\nat Fredonia Alumni Distinguished Achievement Award, 2000; SUNY at Fredonia\nChemistry Dept. Alumni Award, 2000; The Protein Society-Dupont Young\nInvestigator Award, 1999; The Biophysical Society National Lecturer (Award),\n1999; Texas A&M Univ. Honors Program Teacher / Scholar Award, 1994 and the\nSearle Scholar Award, 1991.\n","linknr":140,"url":"Jeffery_W._Kelly","recorded":1376425731,"links":["/w/index.php?title=Jeffery_W._Kelly&action=edit","/w/index.php?title=Jeffery_W._Kelly&action=edit","//bits.wikimedia.org/favicon/wikipedia.ico","/w/opensearch_desc.php","//en.wikipedia.org/w/api.php?action=rsd","//creativecommons.org/licenses/by-sa/3.0/","/w/index.php?title=Special:RecentChanges&feed=atom","http://en.wikipedia.org/wiki/Jeffery_W._Kelly","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=ext.gadget.DRN-wizard%2CReferenceTooltips%2Ccharinsert%2Cteahouse%7Cext.rtlcite%2Cwikihiero%7Cext.uls.nojs%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmw.PopUpMediaTransform%7Cskins.vector&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=ext.visualEditor.viewPageTarget.noscript&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=site&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=startup&only=scripts&skin=vector&*","//bits.wikimedia.org/geoiplookup","//meta.wikimedia.org","#mw-navigation","#p-search","//upload.wikimedia.org/wikipedia/en/f/f4/Ambox_content.png","/wiki/Wikipedia:Biographies_of_living_persons","/wiki/Wikipedia:Citing_sources","/wiki/Wikipedia:Verifiability","/wiki/Wikipedia:Reliable_sources","/wiki/Defamation","/wiki/Medina,_New_York","/wiki/Scripps_Research_Institute","/wiki/La_Jolla,_California","#cite_note-bio1-1","#cite_note-2","#cite_note-3","/wiki/University_of_North_Carolina","/wiki/Rockefeller_University","/wiki/Proteostasis","#cite_note-4","/wiki/Protein_folding","/wiki/Neurodegenerative_disease","/wiki/Alzheimer%27s","/wiki/Parkinson%27s","/wiki/Lysosomal_storage_diseases","#cite_note-5","#cite_note-6","/wiki/Susan_Lindquist","/wiki/Richard_Morimoto","#cite_note-7","#cite_note-8","/wiki/Tafamidis","#cite_note-9","#cite_note-10","/wiki/Proteostasis","#cite_note-11","#cite_note-12","#cite_note-13","/wiki/Proteostasis","#cite_note-14","/wiki/Searle_Scholar","/w/index.php?title=Jeffery_W._Kelly&action=edit&section=1","/w/index.php?title=Jeffery_W._Kelly&veaction=edit&section=1","#cite_ref-bio1_1-0","http://www.scripps.edu/skaggs/kelly/dr_kelly.php?a=l&cid=1","#cite_ref-2","#cite_ref-3","#cite_ref-4","#cite_ref-5","#cite_ref-6","#cite_ref-7","#cite_ref-8","#cite_ref-9","#cite_ref-10","#cite_ref-11","#cite_ref-12","#cite_ref-13","#cite_ref-14","/w/index.php?title=Jeffery_W._Kelly&action=edit&section=2","/w/index.php?title=Jeffery_W._Kelly&veaction=edit&section=2","http://www.scripps.edu/skaggs/kelly/","/w/index.php?title=Jeffery_W._Kelly&action=edit&section=3","/w/index.php?title=Jeffery_W._Kelly&veaction=edit&section=3","/wiki/Authority_control","/wiki/Virtual_International_Authority_File","http://viaf.org/viaf/41024519","/wiki/Wikipedia:Persondata","//en.wikipedia.org/w/index.php?title=Special:CentralAutoLogin/start&type=1x1&from=enwiki","http://en.wikipedia.org/w/index.php?title=Jeffery_W._Kelly&oldid=532081980","/wiki/Help:Category","/wiki/Category:Living_people","/wiki/Category:American_chemists","/wiki/Category:The_Scripps_Research_Institute_faculty","/wiki/Category:1960_births","/wiki/Category:BLP_articles_lacking_sources_from_December_2010","/wiki/Category:Wikipedia_articles_with_VIAF_identifiers","/wiki/Category:Persondata_templates_without_short_description_parameter","/w/index.php?title=Special:UserLogin&returnto=Jeffery+W.+Kelly&type=signup","/w/index.php?title=Special:UserLogin&returnto=Jeffery+W.+Kelly","/wiki/Jeffery_W._Kelly","/wiki/Talk:Jeffery_W._Kelly","#","/wiki/Jeffery_W._Kelly","/w/index.php?title=Jeffery_W._Kelly&action=edit","/w/index.php?title=Jeffery_W._Kelly&veaction=edit","/w/index.php?title=Jeffery_W._Kelly&action=history","#","/w/index.php","//bits.wikimedia.org/static-1.22wmf12/skins/vector/images/search-ltr.png?303-4","/wiki/Main_Page","/wiki/Main_Page","/wiki/Portal:Contents","/wiki/Portal:Featured_content","/wiki/Portal:Current_events","/wiki/Special:Random","https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&utm_medium=sidebar&utm_campaign=C13_en.wikipedia.org&uselang=en","/wiki/Help:Contents","/wiki/Wikipedia:About","/wiki/Wikipedia:Community_portal","/wiki/Special:RecentChanges","//en.wikipedia.org/wiki/Wikipedia:Contact_us","/wiki/Special:WhatLinksHere/Jeffery_W._Kelly","/wiki/Special:RecentChangesLinked/Jeffery_W._Kelly","/wiki/Wikipedia:File_Upload_Wizard","/wiki/Special:SpecialPages","/w/index.php?title=Jeffery_W._Kelly&oldid=532081980","/w/index.php?title=Jeffery_W._Kelly&action=info","//www.wikidata.org/wiki/Q6175781","/w/index.php?title=Special:Cite&page=Jeffery_W._Kelly&id=532081980","/w/index.php?title=Special:Book&bookcmd=book_creator&referer=Jeffery+W.+Kelly","/w/index.php?title=Special:Book&bookcmd=render_article&arttitle=Jeffery+W.+Kelly&oldid=532081980&writer=rl","/w/index.php?title=Jeffery_W._Kelly&printable=yes","#","//www.wikidata.org/wiki/Q6175781#sitelinks-wikipedia","//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License","//creativecommons.org/licenses/by-sa/3.0/","//wikimediafoundation.org/wiki/Terms_of_Use","//wikimediafoundation.org/wiki/Privacy_policy","//www.wikimediafoundation.org/","//wikimediafoundation.org/wiki/Privacy_policy","/wiki/Wikipedia:About","/wiki/Wikipedia:General_disclaimer","//en.wikipedia.org/wiki/Wikipedia:Contact_us","//en.m.wikipedia.org/wiki/Jeffery_W._Kelly","//wikimediafoundation.org/","//bits.wikimedia.org/images/wikimedia-button.png","//www.mediawiki.org/","//bits.wikimedia.org/static-1.22wmf12/skins/common/images/poweredby_mediawiki_88x31.png","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=site&only=scripts&skin=vector&*"],"instances":[],"pdf":[],"categories":["Living people","American chemists","The Scripps Research Institute faculty","1960 births"],"headings":["References","External links","Significant Papers"],"image":["//upload.wikimedia.org/wikipedia/en/f/f4/Ambox_content.png","//en.wikipedia.org/w/index.php?title=Special:CentralAutoLogin/start&type=1x1&from=enwiki","//bits.wikimedia.org/static-1.22wmf12/skins/vector/images/search-ltr.png?303-4","//bits.wikimedia.org/images/wikimedia-button.png","//bits.wikimedia.org/static-1.22wmf12/skins/common/images/poweredby_mediawiki_88x31.png"],"tags":[],"members":[],"related":["Medina,_New_York","Scripps_Research_Institute","La_Jolla,_California","University_of_North_Carolina","Rockefeller_University","Protein_folding","Neurodegenerative_disease","Alzheimer's","Parkinson's","Lysosomal_storage_diseases","Susan_Lindquist","Richard_Morimoto","Tafamidis","Proteostasis","Proteostasis","Searle_Scholar"]}